Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract

Yi Wen Wang, Wei Ming Li, Wen Jeng Wu, Chee Yin Chai, Tsuey Yu Chang, Yin Sun, Chih Jen Cheng, Yow Ling Shiue, Shu Jem Su, Hong Lin Cheng, Hsiao Sheng Liu, Nan Haw Chow

研究成果: Article同行評審

11 引文 斯高帕斯(Scopus)

摘要

Upper urinary tract urothelial carcinoma is a relatively uncommon disease and is diagnosed more frequently at advanced stages. The prognosis of these patients mainly has been related to tumor stage and grade. As a result, the definition of prognostic indicators enabling precise patient selection is mandatory for neoadjuvant or adjuvant therapies. The epithelial membrane protein (EMP2) was identified as one of the up-regulated genes by isoflavones. EMP2 overexpression suppressed foci formation, anchorage-independent growth in vitro, and tumorigenicity in severe combined immunodeficiency mice (all P < 0.05). In addition, a cross-talk between EMP2 and integrins αV and β3 was shown in the regulation of cell adhesion and migration. Higher EMP2 expression was associated with a better progression-free survival (P = 0.008) and cancer-related death (P < 0.001). EMP2 was identified as a tumor-suppressor gene in urinary tract urothelial carcinoma and may be an innovative co-targeting candidate for designing integrin-based cancer therapy.

原文English
頁(從 - 到)709-719
頁數11
期刊American Journal of Pathology
183
發行號3
DOIs
出版狀態Published - 2013 九月

All Science Journal Classification (ASJC) codes

  • 病理學與法醫學

指紋

深入研究「Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract」主題。共同形成了獨特的指紋。

引用此